• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病患者的血糖表型异质性。

Heterogeneity of glycaemic phenotypes in type 1 diabetes.

机构信息

Deep Digital Phenotyping Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.

Bioinformatics Platform, Luxembourg Institute of Health, Strassen, Luxembourg.

出版信息

Diabetologia. 2024 Aug;67(8):1567-1581. doi: 10.1007/s00125-024-06179-4. Epub 2024 May 23.

DOI:10.1007/s00125-024-06179-4
PMID:38780786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11343912/
Abstract

AIMS/HYPOTHESIS: Our study aims to uncover glycaemic phenotype heterogeneity in type 1 diabetes.

METHODS

In the Study of the French-speaking Society of Type 1 Diabetes (SFDT1), we characterised glycaemic heterogeneity thanks to a set of complementary metrics: HbA, time in range (TIR), time below range (TBR), CV, Gold score and glycaemia risk index (GRI). Applying the Discriminative Dimensionality Reduction with Trees (DDRTree) algorithm, we created a phenotypic tree, i.e. a 2D visual mapping. We also carried out a clustering analysis for comparison.

RESULTS

We included 618 participants with type 1 diabetes (52.9% men, mean age 40.6 years [SD 14.1]). Our phenotypic tree identified seven glycaemic phenotypes. The 2D phenotypic tree comprised a main branch in the proximal region and glycaemic phenotypes in the distal areas. Dimension 1, the horizontal dimension, was positively associated with GRI (coefficient [95% CI]) (0.54 [0.52, 0.57]), HbA (0.39 [0.35, 0.42]), CV (0.24 [0.19, 0.28]) and TBR (0.11 [0.06, 0.15]), and negatively with TIR (-0.52 [-0.54, -0.49]). The vertical dimension was positively associated with TBR (0.41 [0.38, 0.44]), CV (0.40 [0.37, 0.43]), TIR (0.16 [0.12, 0.20]), Gold score (0.10 [0.06, 0.15]) and GRI (0.06 [0.02, 0.11]), and negatively with HbA (-0.21 [-0.25, -0.17]). Notably, socioeconomic factors, cardiovascular risk indicators, retinopathy and treatment strategy were significant determinants of glycaemic phenotype diversity. The phenotypic tree enabled more granularity than traditional clustering in revealing clinically relevant subgroups of people with type 1 diabetes.

CONCLUSIONS/INTERPRETATION: Our study advances the current understanding of the complex glycaemic profile in people with type 1 diabetes and suggests that strategies based on isolated glycaemic metrics might not capture the complexity of the glycaemic phenotypes in real life. Relying on these phenotypes could improve patient stratification in type 1 diabetes care and personalise disease management.

摘要

目的/假设:本研究旨在揭示 1 型糖尿病患者的血糖表型异质性。

方法

在法国 1 型糖尿病学会(SFDT1)的研究中,我们通过一系列互补指标来描述血糖异质性:HbA、血糖控制目标范围内时间(TIR)、血糖控制目标范围外时间(TBR)、变异系数(CV)、Gold 评分和血糖风险指数(GRI)。应用判别维度缩减树(DDRTree)算法,我们创建了一个表型树,即二维可视化映射。我们还进行了聚类分析以作比较。

结果

我们纳入了 618 名 1 型糖尿病患者(52.9%为男性,平均年龄 40.6 岁[SD 14.1])。我们的表型树确定了七种血糖表型。二维表型树由近端区域的主分支和远端区域的血糖表型组成。第一维,水平维度,与 GRI(系数[95%CI])呈正相关(0.54[0.52,0.57]),与 HbA(0.39[0.35,0.42])、CV(0.24[0.19,0.28])和 TBR(0.11[0.06,0.15])呈正相关,与 TIR(-0.52[-0.54,-0.49])呈负相关。垂直维度与 TBR(0.41[0.38,0.44])、CV(0.40[0.37,0.43])、TIR(0.16[0.12,0.20])、Gold 评分(0.10[0.06,0.15])和 GRI(0.06[0.02,0.11])呈正相关,与 HbA(-0.21[-0.25,-0.17])呈负相关。值得注意的是,社会经济因素、心血管风险指标、视网膜病变和治疗策略是血糖表型多样性的重要决定因素。表型树比传统聚类更能揭示 1 型糖尿病患者的临床相关亚组。

结论/解释:本研究加深了我们对 1 型糖尿病患者复杂血糖谱的理解,并表明基于孤立血糖指标的策略可能无法捕捉到现实生活中血糖表型的复杂性。依赖这些表型可以改善 1 型糖尿病护理中的患者分层,并使疾病管理个体化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/8536081764cf/125_2024_6179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/46a236c4f058/125_2024_6179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/dd7dffbc35c1/125_2024_6179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/39db43b21606/125_2024_6179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/8536081764cf/125_2024_6179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/46a236c4f058/125_2024_6179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/dd7dffbc35c1/125_2024_6179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/39db43b21606/125_2024_6179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bde1/11343912/8536081764cf/125_2024_6179_Fig4_HTML.jpg

相似文献

1
Heterogeneity of glycaemic phenotypes in type 1 diabetes.1 型糖尿病患者的血糖表型异质性。
Diabetologia. 2024 Aug;67(8):1567-1581. doi: 10.1007/s00125-024-06179-4. Epub 2024 May 23.
2
Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes.1 型糖尿病成人真实环境下的睡眠质量与血糖变异性。
Diabetologia. 2021 Oct;64(10):2159-2169. doi: 10.1007/s00125-021-05500-9. Epub 2021 Jun 17.
3
Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.使用连续血糖监测系统研究血糖控制良好的 2 型糖尿病患者的血糖变异性。
J Assoc Physicians India. 2024 Jan;72(1):18-21. doi: 10.59556/japi.71.0441.
4
Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.血糖风险指数揭示了与1型糖尿病缓解状态相关的不同血糖变异性模式。
Diabetologia. 2024 Jan;67(1):42-51. doi: 10.1007/s00125-023-06042-y. Epub 2023 Oct 27.
5
Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.胰岛素起始治疗对基层医疗2型糖尿病队列血糖变异性和血糖谱的影响:来自INITIATION研究的连续血糖监测数据分析
Diabet Med. 2016 Jun;33(6):803-11. doi: 10.1111/dme.12979. Epub 2015 Oct 27.
6
Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.在一个大型的 1 型糖尿病儿童和青少年队列中,HbA1c 与血糖控制和血糖变异性的连续血糖监测指标之间的关系。
Diabetes Res Clin Pract. 2021 Jul;177:108933. doi: 10.1016/j.diabres.2021.108933. Epub 2021 Jun 30.
7
The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.6 天皮下葡萄糖依赖性胰岛素多肽输注对 1 型糖尿病患者血糖范围内时间的影响:一项随机、双盲、安慰剂对照交叉试验。
Diabetologia. 2021 Nov;64(11):2425-2431. doi: 10.1007/s00125-021-05547-8. Epub 2021 Aug 17.
8
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohort.1 型糖尿病运动倡议(T1DEXI)队列研究:成年人每日步数分类与连续血糖监测指标的相关性分析。
Diabetologia. 2024 Jun;67(6):1009-1022. doi: 10.1007/s00125-024-06127-2. Epub 2024 Mar 19.
9
Factors associated with Glycemia Risk Index in a cohort of patients with type 1 Diabetes Mellitus and Latent Autoimmune Diabetes In Adults (LADA).与 1 型糖尿病和成人隐匿性自身免疫性糖尿病(LADA)患者队列中血糖风险指数相关的因素。
Endocrine. 2024 Nov;86(2):574-583. doi: 10.1007/s12020-024-03901-5. Epub 2024 Jun 6.
10
Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.使用连续血糖监测评估慢性肾脏病糖尿病患者的血糖控制标志物。
Nephrology (Carlton). 2012 Feb;17(2):182-8. doi: 10.1111/j.1440-1797.2011.01517.x.

引用本文的文献

1
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global Council.糖尿病研究与照护中的全球挑战:何去何从?欧洲糖尿病研究协会全球委员会的评估
Diabetologia. 2025 Sep 10. doi: 10.1007/s00125-025-06504-5.
2
Single-cell RNA sequencing technology was employed to construct a risk prediction model for genes associated with pyroptosis and ferroptosis in lung adenocarcinoma.采用单细胞RNA测序技术构建肺腺癌中与细胞焦亡和铁死亡相关基因的风险预测模型。
Respir Res. 2025 Jul 18;26(1):249. doi: 10.1186/s12931-025-03323-5.
3
Elucidating the heterogeneity of prediabetes through subphenotyping with a two-dimensional tree structure.

本文引用的文献

1
Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study.血糖风险指数作为评估 1 型糖尿病儿童和青少年血糖控制安全性的新指标:一项观察性、多中心、真实世界队列研究。
Diabetes Technol Ther. 2023 Jul;25(7):507-512. doi: 10.1089/dia.2023.0040. Epub 2023 May 26.
2
Clinically Similar Clusters of Daily Continuous Glucose Monitoring Profiles: Tracking the Progression of Glycemic Control Over Time.临床相似的日常连续血糖监测图谱簇:跟踪血糖控制随时间的进展。
Diabetes Technol Ther. 2023 Aug;25(8):519-528. doi: 10.1089/dia.2023.0117.
3
通过二维树状结构的亚表型分析阐明糖尿病前期的异质性。
Cell Rep Med. 2025 Jul 15;6(7):102212. doi: 10.1016/j.xcrm.2025.102212. Epub 2025 Jul 2.
4
Inflammatory Transformation of Skin Basal Cells as a Key Driver of Cutaneous Aging.皮肤基底细胞的炎症转变是皮肤衰老的关键驱动因素。
Int J Mol Sci. 2025 Mar 14;26(6):2617. doi: 10.3390/ijms26062617.
5
Machine Learning Algorithms Based on Time Series Pre-Clustering for Nocturnal Glucose Prediction in People with Type 1 Diabetes.基于时间序列预聚类的机器学习算法用于1型糖尿病患者夜间血糖预测
Diagnostics (Basel). 2024 Oct 30;14(21):2427. doi: 10.3390/diagnostics14212427.
Glycemic Risk Index Profiles and Predictors Among Diverse Adults With Type 1 Diabetes.
血糖风险指数特征及不同类型 1 型糖尿病患者的预测因素。
J Diabetes Sci Technol. 2024 Sep;18(5):1070-1078. doi: 10.1177/19322968231164151. Epub 2023 Mar 30.
4
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病中的糖尿病管理:美国糖尿病协会 (ADA) 和改善全球肾脏病预后组织 (KDIGO) 的共识报告。
Kidney Int. 2022 Nov;102(5):974-989. doi: 10.1016/j.kint.2022.08.012. Epub 2022 Oct 3.
5
Epidemiology and risk factors of hypoglycemia in subjects with type 1 diabetes in Brazil: a cross-sectional, multicenter study.巴西 1 型糖尿病患者低血糖的流行病学和危险因素:一项横断面、多中心研究。
Arch Endocrinol Metab. 2022 Nov 17;66(6):784-791. doi: 10.20945/2359-3997000000523. Epub 2022 Oct 3.
6
Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes.基本连续血糖监测指标:糖尿病血糖控制的主要维度。
Diabetes Technol Ther. 2022 Nov;24(11):797-804. doi: 10.1089/dia.2022.0104. Epub 2022 Jul 5.
7
Hyperglycemia and hypoglycemia exposure are differentially associated with micro- and macrovascular complications in adults with Type 1 Diabetes.高血糖和低血糖暴露与 1 型糖尿病成人的微血管和大血管并发症有差异相关。
Diabetes Res Clin Pract. 2022 Jul;189:109938. doi: 10.1016/j.diabres.2022.109938. Epub 2022 Jun 1.
8
Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes.2 型糖尿病表型、疾病进展和药物反应的异质性。
Nat Med. 2022 May;28(5):982-988. doi: 10.1038/s41591-022-01790-7. Epub 2022 May 9.
9
Outcomes in Pump- and CGM-Baseline Use Subgroups in the International Diabetes Closed-Loop Trial.国际糖尿病闭环临床试验中使用胰岛素泵和 CGMS 患者的基线使用结果。
J Diabetes Sci Technol. 2023 Jul;17(4):935-942. doi: 10.1177/19322968221089361. Epub 2022 Apr 26.
10
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.经临床医生评估验证的用于连续血糖监测的低血糖和高血糖血糖风险指数(GRI)。
J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242. doi: 10.1177/19322968221085273. Epub 2022 Mar 29.